News & Events

TRASIS offers the widest range of PSMA tracers to be produced on the same synthesizer.

Düsseldorf, 15 October 2018.

Prostate cancer is the second leading cause of cancer death for men in many parts of the world. For imaging, PSMA-based radio tracers target the PSMA  (Prostate Specific Membrane Antigen) transmembrane glycoprotein, which is strongly upregulated in prostate cancer cells. In this way, the PET tracer provides important molecular information on cancer and metastases localization within the prostate.

AllinOne family versatility proven


Ans, 11 October 2018 – We are pleased to announce that we have entered into an agreement with RQS. Ruffani Quality Solutions will be our agent and provide service support for Germany and Austria.

With decades of experience and jointly to Trasis, RQS are committed to listening to our customers in order to provide the most effective solution. Located in Heideneau, RQS is also a valued partner and able to offer technical support in Germany and Austria. Fri, 07/13/2018 - 11:47

Meet us @ EANM

You won’t miss the chance to meet us this year at EANM.

You can make an appointment, meet us on our booth or attend our community meeting.

  • The appointment will leave you for a chosen moment with one of our expert.
  • 29 is our booth #, we will be pleased to listen your radiopharmaceuticals challeges.
  • Our community meeting is the first step to get into the Trasis Community. It is the best way to discover Trasis’ last outcomes in a relaxed atmosphere.